WEISENTHAL LARRY MARK has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are CHENGDU YIANBO BIOTECHNOLOGY CO LTD, GENTIUM S R L and QIAGEN AUSTRALIA HOLDING PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 3 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Weisenthal Larry Mark | 13 |
Publication | Filing date | Title |
---|---|---|
EP2560667A1 | Method to detect endothelial cell massive calcium accumulation death | |
EP2294210A2 | Efficient wellbeing assessment and improved treatment protocol | |
CA2633494A1 | Microaggregates including endothelial cells |